Gene · 3447
IFNA13: interferon alpha 13
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. IFNA13: interferon alpha 13. Genes, record 3447. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/3447
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| A0A087WWS6 | Interferon alpha-13 | 190 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents29
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 18504 | A0A087WWS6 | Espacenet |
| JP 2025169942 A | 2025-11-14 | 1092 | A0A087WWS6 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 6728 | A0A087WWS6 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 18504 | A0A087WWS6 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 6728 | A0A087WWS6 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 6728 | A0A087WWS6 | Espacenet |
| JP 2024109657 A | 2024-08-14 | 6735 | A0A087WWS6 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 41150 | A0A087WWS6 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 144121 | A0A087WWS6 | Espacenet |
| JP 2021536249 A | 2021-12-27 | 7033 | A0A087WWS6 | Espacenet |
1 to 10 of 29
See all 29 patentsDrugs3
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
Trials10
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
| Trial | Drug | Phase | Results first posted | Source |
|---|---|---|---|---|
| NCT01283139 | SIFALIMUMAB | PHASE2 | 2016-07-11 | ClinicalTrials.gov |
| NCT01031836 | SIFALIMUMAB | PHASE2 | 2018-11-19 | ClinicalTrials.gov |
| NCT00979654 | SIFALIMUMAB | PHASE2 | 2016-08-23 | ClinicalTrials.gov |
| NCT00962832 | RONTALIZUMAB | PHASE2 | ClinicalTrials.gov | |
| NCT00657189 | SIFALIMUMAB | PHASE2 | ClinicalTrials.gov | |
| NCT00541749 | RONTALIZUMAB | PHASE1 | ClinicalTrials.gov | |
| NCT00533091 | SIFALIMUMAB | PHASE1 | ClinicalTrials.gov | |
| NCT00482989 | SIFALIMUMAB | PHASE1 | ClinicalTrials.gov | |
| NCT00472758 | SIFALIMUMAB | PHASE1 | ClinicalTrials.gov | |
| NCT00299819 | SIFALIMUMAB | PHASE1 | ClinicalTrials.gov |
NIH grants293
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | IFNA13 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 2 | 2025 |
| P30CA015083 | Mayo Clinic Comprehensive Cancer Center Support Grant | 2 | 2025 |
| P30DK043351 | Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital | 2 | 2025 |
| R01AI163029 | Inborn errors of immunity in patients with life-threatening COVID-19 | 2 | 2025 |
| UL1TR001866 | Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success | 2 | 2025 |
| ZIAAI000887 | Role of HIV Envelope Proteins In Viral Replication and HIV Pathogenesis | 2 | 2025 |
| P01AG047200 | Comparative genomics of longevity and Alzheimer's disease | 1 | 2025 |
| P01AG051449 | Role of Retrotransposon Activity in Neurodegeneration and Alzheimer's Disease | 1 | 2025 |
| P20GM103427 | Nebraska Research Network in Functional Genomics | 1 | 2025 |
| P30AI027763 | UCSF-Bay Area Center for AIDS Research | 1 | 2025 |
1 to 10 of 293Source NIH's project files
See all 293 nih grantsPapers246
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fetal and Neonatal Immune Response to Congenital Cytomegalovirus (cCMV) Infection: A Systematically Conducted Scoping Review. | Viruses | 2026 | 41754585 | PubTator, text mining | PubMed |
| High sensitivity measurement of circulating interferon proteins in systemic lupus erythematosus. | Clin Exp Rheumatol | 2026 | 41487114 | PubTator, text mining | PubMed |
| Meta-DHGNN: method for CRS-related cytokines analysis in CAR-T therapy based on meta-learning directed heterogeneous graph neural network. | Brief Bioinform | 2024 | 38546326 | PubTator, text mining | PubMed |
| Delivery of Interferon β-Encoding Plasmid via Lipid Nanoparticle Restores Interferon β Expression to Enhance Antitumor Immunity in Colon Cancer. | ACS Nano | 2024 | 38319978 | PubTator, text mining | PubMed |
| Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children. | J Exp Med | 2024 | 38175961 | PubTator, text mining | PubMed |
| Senescence-associated secretory phenotypes in mesenchymal cells contribute to cytotoxic immune response in oral lichen planus. | Immun Ageing | 2023 | 38053160 | PubTator, text mining | PubMed |
| Genome, Metabolism, or Immunity: Which Is the Primary Decider of Pancreatic Cancer Fate through Non-Apoptotic Cell Death? | Biomedicines | 2023 | 37893166 | PubTator, text mining | PubMed |
| Virus-specific and shared gene expression signatures in immune cells after vaccination in response to influenza and vaccinia stimulation. | Front Immunol | 2023 | 37600811 | PubTator, text mining | PubMed |
| Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma. | BMC Cancer | 2023 | 37543576 | PubTator, text mining | PubMed |
| Breakthrough infection evokes the nasopharyngeal innate immune responses established by SARS-CoV-2-inactivated vaccine. | Front Immunol | 2023 | 37457721 | PubTator, text mining | PubMed |
1 to 10 of 246
See all 246 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/3447
GET https://conductscience.org/api/genes/v1/3447/patents?page=2